戻る Agenda
Session 11: Bitesize Topics & Open Community Forum
Session Chair(s)
Francine Lane, MBA
Senior Director of Product Management
Citeline, United States
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
Your Voice, Your Topics! We're thrilled to bring you a session featuring topics proposed by the DIA Disclosure Community. We've listened to your suggestions, and this session is designed to address your most pressing concerns and interests in the field of disclosure and transparency. Join us for an engaging and interactive discussion shaped by your input!
Speaker(s)
Update on Privacy Methodology
Boris Grimm
Boehringer Ingelheim, Germany
Chapter Head and Capability Owner of Clinical Trial Transparency and Data Sharin
Update on Privacy Methodology
Jeppe G. Manuel, MLIS
Novo Nordisk, Denmark
Principal R&D Data Privacy Specialist
Complex Clinical Trials
Scott Feiner
AbbVie, United States
Senior Manager, Trial Disclosure
CTIS and its impact on Investigator sponsored trials (ISS) or investigator-initiated trials (IIS)
Sameer Sharma, MPHARM
Merck KGaA, Germany
Associate Director, Clinical Trial Transparency
IP Dosing and Transparency issues
Scott Feiner
AbbVie, United States
Senior Manager, Trial Disclosure